CLINICAL_TRIALS
withdrawal
· 2017-06-27
Clinical Trial Update: Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP) [Phase 4]
Summary
A Phase 4 trial evaluating corticosteroid therapy for Pneumocystis jirovecii pneumonia has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: George Washington University | Conditions: Pneumocystis Carinii Pneumonia | Phase 4 | Status: WITHDRAWN